SOUTH ORANGE, N.J.--(BUSINESS WIRE)--The Law Firm of Arons & Arons, LLC. has initiated an investigation of NuVasive, Inc. (“NuVasive or the “Company”) (NASDAQ:NUVA) on behalf of the company’s investors for possible violations of federal securities law.
NuVasive, Inc. investors who would like to discuss this investigation and their legal options should contact Arons & Arons, LLC. (Jeffrey S. Arons, Esq.) at (973) 762-0795, (877) 512-7667 or email us at email@example.com. For more information visit https://www.aronslaw.net/securities-fraud
There is reporting that GlassHouse Research, a short seller, has accused the medical device company NuVasive, Inc. of “irregular accounting” practices and says the stock has more than 50 percent downside. There are claims that NuVasive has been using accounting tricks to mask the fact that the business is in decline. According to one report, there are allegations that NuVasive has been inflating its earnings and growth numbers using nefarious strategies such as channel stuffing, pulling forward revenue, and delaying normalized expenses. GlassHouse has set a $24.18 price target for NuVasive and is predicting a major miss sometime in the next three quarters. The Company’s shares have fallen to $4.26 per share, or 7.4%.
If you are an investor in NuVasive, or have information pertaining to this investigation, you are encouraged to contact Arons & Arons, LLC. (Jeffrey Arons, Esq.) at (973) 762-0795, (877) 512-7667 or email us at firstname.lastname@example.org. For more information visit https://www.aronslaw.net/securities-fraud
Arons & Arons, LLC., is a family oriented firm, that provides representation for individuals, including investors who have been victimized by securities fraud. Our attorneys understand the financial and emotional trauma that securities fraud can cause, and we are relentless in our efforts to hold corporate wrongdoers accountable and obtain compensation for our clients. For over 30 years our attorneys have provided personal, accessible, and effective legal representation for our clients. www.aronslaw.net
This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and ethical rules.